mRNA test kitchens

Enough of the early challenges in mRNA have been solved to convince several pharmas and biotechs to enter into partnerships to create products capitalizing on the technology’s advantages over existing modalities.

The deals span applications such as infectious disease vaccines, immunomodulators for cancer and protein replacement in rare disease; however, forays into broader protein replacement applications are still scarce...